Preventerm is derived from a naturally occurring amino acid derivative and thiol reducing agent This drug is exceptionally easy to manufacture, as it draws from a widely available molecule Preventerm is ready to begin Phase II testing by our research team
Inducterm is created from ubiquitous collagenase, an enzyme that governs the breakdown of collagen in various human and animal systems
Collagenase is already FDA approved for unrelated indications and in use by Biospecifics Technology Corp. (US) for tissue healing therapies
Inducterm is ready to begin clinical trials Phase II.
With this device dual use Local immunological injection: For induction if labor – 1 Injection
For the prevention and treatment of preterm labor injections with a two weeks interval.